BRS-3 agonist Compound A

CAS No. ——

BRS-3 agonist Compound A( —— )

Catalog No. M17034 CAS No. ——

A potent, selective, orally active bombesin receptor subtype-3 (BRS-3) agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BRS-3 agonist Compound A
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective, orally active bombesin receptor subtype-3 (BRS-3) agonist.
  • Description
    A potent, selective, orally active bombesin receptor subtype-3 (BRS-3) agonist with EC50 of 250/100 nM for human/rat BRS-3, resp+H1437+M1438.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Bombesin Receptor
  • Recptor
    Bombesin Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    428.532
  • Molecular Formula
    C27H28N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    R-6-benzyl-N-tert-butyl-9-methoxy-7-oxo-6,7-dihydro-5H-dibenzo[c,e]azepine-5-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Nio Y, et al. Endocrinology. 2017 May 1;158(5):1298-1313.
molnova catalog
related products
  • (S)-BRS-3 agonist Co...

    The distomer of BRS-3 agonist Compound A, shows no activity for bombesin receptor subtype-3 (BRS-3) with EC50>10 uM.

  • Bombesin

    Bombesin is a 14-amino acid peptide originally isolated from the skin of the European fire-bellied toad (Bombina bombina). It has two known homologs in mammals called neuromedin B and gastrin-releasing peptide.

  • PD176252

    PD176252 is a potent BB1 and BB2 antagonist with inhibitory effects on BB1 and BB2 receptors.PD176252 acts as a small molecule GRPR inhibitor and FPR1/FPR2 agonist to inhibit the growth and proliferation of a variety of cancer cells.